Nivolumab with or without Relatlimab in Untreated Advanced Melanoma. Reply

Hussein A. Tawbi; F. Stephen Hodi; Georgina V. Long

doi:10.1056/NEJMc2201558

Nivolumab with or without Relatlimab in Untreated Advanced Melanoma. Reply

Hussein A. Tawbi, F. Stephen Hodi, Georgina V. Long

Melanoma Medical Oncology

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	1860-1861
Number of pages	2
Journal	The New England journal of medicine
Volume	386
Issue number	19
DOIs	https://doi.org/10.1056/NEJMc2201558
State	Published - May 12 2022

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc2201558

Cite this

@article{7ec489e9db454b04865a9fdb8f50cd35,

title = "Nivolumab with or without Relatlimab in Untreated Advanced Melanoma. Reply",

author = "Tawbi, {Hussein A.} and Hodi, {F. Stephen} and Long, {Georgina V.}",

year = "2022",

month = may,

day = "12",

doi = "10.1056/NEJMc2201558",

language = "English (US)",

volume = "386",

pages = "1860--1861",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "19",

}

TY - JOUR

T1 - Nivolumab with or without Relatlimab in Untreated Advanced Melanoma. Reply

AU - Tawbi, Hussein A.

AU - Hodi, F. Stephen

AU - Long, Georgina V.

PY - 2022/5/12

Y1 - 2022/5/12

UR - http://www.scopus.com/inward/record.url?scp=85129926739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85129926739&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2201558

DO - 10.1056/NEJMc2201558

M3 - Letter

C2 - 35544394

AN - SCOPUS:85129926739

SN - 0028-4793

VL - 386

SP - 1860

EP - 1861

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 19

ER -

Nivolumab with or without Relatlimab in Untreated Advanced Melanoma. Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this